{"nctId":"NCT03249376","briefTitle":"Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally","startDateStruct":{"date":"2017-11-27","type":"ACTUAL"},"conditions":["Bipolar Depression"],"count":381,"armGroups":[{"label":"Lumateperone","type":"EXPERIMENTAL","interventionNames":["Drug: Lumateperone"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Other: Placebo"]}],"interventions":[{"name":"Lumateperone","otherNames":["ITI-007"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Major Inclusion Criteria:\n\n* male or female subjects of any race, ages 18-75 inclusive, with a clinical diagnosis of Bipolar I or Bipolar II disorder\n* experiencing a current major depressive episode\n* able to provide written informed consent\n\nMajor Exclusion Criteria:\n\n* any female subject who is pregnant or breast-feeding\n* any subject judged to be medically inappropriate for study participation","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) Total Score","description":"The Montgomery-Åsberg Depression Rating Scale (MADRS) is a clinician-rated 10 item scale to assess depressive symptoms. Each item is rated on a 7-point scale from 0-6. The total score ranges from 0 to 60 with a higher score indicating increased severity of depressive symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-16.70","spread":"0.693"},{"groupId":"OG001","value":"-12.12","spread":"0.677"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Clinical Global Impression Scale, Bipolar Version (CGI-BP-S) Total Score","description":"The Clinical Global Impression Scale, Bipolar version (CGI-BP-S) total score is a clinician-rated scale that measures the patient's current illness state on a 3 to 21 point scale where a higher score is associated with greater illness severity.. Each domain (depression, mania, and overall illness) is rated from 1 (not ill at all) to 7 (among the most extremely ill) and the 3 scores are added to obtain the total score.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.48","spread":"0.170"},{"groupId":"OG001","value":"-2.54","spread":"0.167"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form (Q-LES-Q-SF) Percent Score","description":"The Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form (Q-LES-Q-SF) is a 14 item patient self-reported questionnaire that assesses how satisfied a patient is, using a 5-point scale from 1-very poor to 5-very good.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19.4","spread":"1.49"},{"groupId":"OG001","value":"14.9","spread":"1.45"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":188},"commonTop":["Headache","Dizziness","Somnolence","Nauseau"]}}}